Antisoma Share Price (ASM)
| Bid price | 0.00 | Open price | 0.00 |
|---|---|---|---|
| Ask price | 0.00 | Prev close | 1.78 |
| High price | 0.00 | Spread | 0.00% |
| Low price | 0.00 | Volume | 0 |
Register now for FREE live Antisoma share prices, Antisoma stock quotes, charts, trades and FREE Antisoma company fundamentals, market news and much much more. Why not upgrade to a premium service and get Antisoma Level 2 Data, indepth research tools and investor commentary for Antisoma (ASM) and other London Stock Exchange equities.
Antisoma Share Price Chart
Register now for FREE Antisoma share price charts
Antisoma Share Price Information
| Name | Antisoma | Epic | ASM |
|---|---|---|---|
| Activites | Develops novel products for the treatment of cancer | Reuters | ASM.L |
| ISIN | GB0055696032 | Google Finance | LON:ASM |
| Share Price (p) | 0.00 | Prev. Share Price (p) | 1.78 |
|---|---|---|---|
| Shares in Issue (m) | 639 | Market Cap (£m) | 11 |
| PE Ratio (x) | -0.24 | Div per share (p) | 0.00 |
| Div yield (%) | 0.00 | Div cover (x) | |
| EPS (p) | -10.90 | PEG |
Register now for FREE Antisoma company fundamentals
Antisoma Director Deals
| Dec.Date | Type | Director | Pos | No. of Shares |
|---|---|---|---|---|
| 03/12/2010 | LOF | Birgit Stattin-Norinder | RES | 11,396 |
| 01/11/2010 | LOF | Birgit Stattin-Norinder | RES | 10,582 |
| 01/11/2010 | LOF | Barry Price | RES | 19,841 |
| 01/10/2010 | LOF | Michael Lewis | NED | 48,611 |
| 01/10/2010 | LOF | Birgit Stattin-Norinder | RES | 12,847 |
Antisoma Company News
ASM International N.V. announces confirmation t...
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} ASM International N.V. announces confirmation to carry out study into market valuation of the Company ALMERE, The Netherlands - May 16,...
ASM International N.V. announces Voting Results...
ASM International N.V. announces Voting Results of Annual General Meeting of Shareholders body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} ALMERE, The Netherlands - May 15, 2012 - ASM...
ASM INTERNATIONAL N.V. REPORTS PROGRESS ON SHAR...
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} ASM INTERNATIONAL N.V. REPORTS PROGRESS ON SHARE BUY BACK PROGRAM ALMERE, The Netherlands - May 9, 2012 - ASM International N.V. (NASDAQ:...
Register now for FREE Antisoma company news
Antisoma Share Price Discussions
ANTISOMA - 55% DROP 2DAY. Will it rebound? (ASM)
LONDON (AFX) - Antisoma PLC announced that R1549, its lead drug formerly known as Pemtumomab, has failed to meet its primary endpoint in a Phase III study in ovarian cancer. The group, which specialises in the development of novel products for the treatment of cancer, said that the...
Soemthing about ASM, it may double or halves (ASM)
Antisoma (LSE: ASM.L - news) shares could double if the ovarian cancer drug, R1549, is successful, and halve if it is not says the Independent. Given the probability of success, reckoned to be about 65%, that looks a gamble worth taking says the paper.
Hoping for another week of rocket propulsion (ASM)
Just added a small holding to my small holding, which means it's now a medium holding...sorry better get some coffee!
Register now for FREE Antisoma share price discussions